Compare Humana Inc (HUM) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Zillow Group Inc Class C — how do they compare? Humana Inc trades at $445 (market cap $47.61B), while Zillow Group Inc Class C trades at $29.24 (market cap $6.17B). The key difference: Humana Inc is far larger — about 7.7× Zillow Group Inc Class C's market cap, and Humana Inc pays a 0.89% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Zillow Group Inc Class C for 39 Days on average.
| HUM | Z | |
|---|---|---|
Market Cap | $47.61B | $6.17B |
Volume | 1,827,332 | 2,822,928 |
Sector | Health | Media |
52-Week High | $409.85 | $78.04 |
52-Week Low | $163.67 | $27.13 |
Typical Hold Time | 53 Days | 39 Days |
Enterprise Value | $54.97B | $6.04B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Zillow Group (Z) trades at $27.28, down 1.52% amid bearish technical signals and a challenging housing market. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability with net income of $23M. Recent earnings beat expectations in Q1 and Q2 2026, though Q4 2025 missed. Analyst consensus remains mixed with a $60.33 price target representing significant upside potential from current levels.
The stock presents a compelling risk-reward opportunity with strong analyst price targets but faces headwinds from rising mortgage rates and housing market volatility. Zillow's strategic pivot to an integrated transaction platform and AI integration positions it for long-term growth, though near-term performance depends on housing market stabilization and execution of their business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
